Four Spanish start-ups build businesses around menopause care, from supplements to company programmes

The story so far, in brief; the legwork, and the full article, stay with the original outlet.

Menopause, long a subject people avoided, now has a Spanish start-up scene. Domma, founded in 2021 and run by co-CEOs Mireia Roca and Cristina Martínez, sells hormone-free supplements made in Spain. It backs them with five of its own clinical studies, two of them double-blind, and an AI assistant called Luna. It counts a community of more than 350,000 women and a registry of over 100,000 profiles. Madequa, co-led by Sofía Francés, worked out its approach with an advisory board of 50 specialist doctors and puts its regimen in a single daily sachet of four capsules. Its Menomade study, led by gynaecologist Maite Cusidó with more than 90 women, found that over 70% reported improvements from the first month.

Maia Care is backed by GCO Ventures, the venture arm of insurer Catalana Occidente, and led by Nora Viladomiu Cusí. It offers a free symptom check based on the Cervantes Scale of the Spanish menopause association, AEEM, then links users with specialists in gynaecology, nutrition, psychology, sexology and pelvic-floor physiotherapy. In its own survey of over 500 women, 66% said they felt lonely during the process. "We have broken the silence, but not yet the loneliness," Viladomiu said.

Olira comes from the team behind WOOM, a fertility platform acquired in 2022, and is led by Clelia Morales with Blanca Fernández as CMO. It also sells health programmes to employers. Its study of more than 3,000 women in Spain found that 85% reported symptoms and fewer than 10% were being treated, which, from a market-sizing perspective, is a fairly clear gap.